HILLSDALE INVESTMENT MANAGEMENT INC. Intra-Cellular Therapies, Inc. Transaction History

HILLSDALE INVESTMENT MANAGEMENT INC. portfolio value:

$4.37M
portfolio value

HILLSDALE INVESTMENT MANAGEMENT INC. quarter portfolio value change:

-18.48%
quarter

Intra-Cellular Therapies, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +566.67% 79.9K shares 3.56M $46.53 94K
Q2 2022 share Increase 0.00% 14.1K shares 805K $57.08 14.1K